The “Pharmacovigilance & Drug Safety Software Market Research Report by Product, by Clinical Trial, by Method, by Distribution, by End User, by Region – Global Forecast to 2027 – Cumulative Impact of COVID-19″ report has been added to ResearchAndMarkets.com’s offering.
The Global Pharmacovigilance & Drug Safety Software Market size was estimated at USD 213.72 million in 2020, is expected to reach USD 231.64 million in 2021, and is projected to grow at a CAGR of 8.75% to reach USD 384.49 million by 2027.
In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2027 are considered the forecast period.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Ongoing research by the publisher amplifies their research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward.
The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects.
It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others.
Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate.
The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Market Segmentation & Coverage:
- Based on Product, the market was studied across Adverse Event Reporting Software, Drug Safety Audits Software, Fully Integrated Software, and Issue Tracking Software.
- Based on Clinical Trial, the market was studied across Phase I, Phase II, Phase III, Phase IV, and Pre-clinical.
- Based on Method, the market was studied across Cohort Event Monitoring, EHR Mining, Intensified ADR Reporting, Spontaneous Reporting, and Targeted Spontaneous Reporting.
- Based on Distribution, the market was studied across On-Cloud and On-Premise.
- Based on End User, the market was studied across Business Process Outsourcing Firms, Contract Research Organizations, Pharma & Biotech Companies, and Pharmacovigilance Service Providers.
- Based on Region, the market was studied across the Americas, Asia-Pacific, and Europe, Middle East & Africa.
Company Usability Profiles:
- 4C PHARMA SOLUTIONS
- AB Cube
- Accenture
- Advera Health Analytics, Inc.
- ArisGlobal
- Clinevo Technologies
- Cognizant
- Ennov
- Extedo GMBH
- Indegene
- IQVIA Inc.
- Online Business Applications
- Oracle Corporation
- Sarjen Systems Pvt
- Sparta Systems
- UMBRA Global LLC
- United BioSource Corporation
- VigiFlow
- Wipro
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Need for pharmacovigilance and drug safety monitoring by product developers, license holders and clinical investigators
5.1.1.2. Need to reduce time spent reviewing medical literature for aggregate reports and safety signals
5.1.1.3. Increasing investment by pharmaceuticals companies
5.1.1.4. Highly regulated pharmacovigilance space
5.1.2. Restraints
5.1.2.1. Expensive deployments
5.1.3. Opportunities
5.1.3.1. Third party dependency for pharmacovigilance and drug safety
5.1.3.2. Use of AI and machine learning models automatically to identify references in scientific literature
5.1.4. Challenges
5.1.4.1. Limited awareness
5.2. Cumulative Impact of COVID-19
6. Pharmacovigilance & Drug Safety Software Market, by Product
6.1. Introduction
6.2. Adverse Event Reporting Software
6.3. Drug Safety Audits Software
6.4. Fully Integrated Software
6.5. Issue Tracking Software
7. Pharmacovigilance & Drug Safety Software Market, by Clinical Trial
7.1. Introduction
7.2. Phase I
7.3. Phase II
7.4. Phase III
7.5. Phase IV
7.6. Pre-clinical
8. Pharmacovigilance & Drug Safety Software Market, by Method
8.1. Introduction
8.2. Cohort Event Monitoring
8.3. EHR Mining
8.4. Intensified ADR Reporting
8.5. Spontaneous Reporting
8.6. Targeted Spontaneous Reporting
9. Pharmacovigilance & Drug Safety Software Market, by Distribution
9.1. Introduction
9.2. On-Cloud
9.3. On-Premise
10. Pharmacovigilance & Drug Safety Software Market, by End User
10.1. Introduction
10.2. Business Process Outsourcing Firms
10.3. Contract Research Organizations
10.4. Pharma & Biotech Companies
10.5. Pharmacovigilance Service Providers
For more such updates and perspectives around Digital Innovation, IoT, Data Infrastructure, AI & Cybersecurity, go to AI-Techpark.com.
